Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126000603 | 12600060 | 3 | F | 201607 | 20160829 | 20160727 | 20160906 | EXP | PHHY2016AR101542 | NOVARTIS | 65.27 | YR | F | Y | 0.00000 | 20160906 | CN | COUNTRY NOT SPECIFIED | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126000603 | 12600060 | 1 | PS | DIOVAN | VALSARTAN | 1 | Unknown | 1 DF (VALSARTAN 160 MG), QD (3 YEARS AGO APPROXIMATELY) | 88229 | 21283 | 1 | DF | TABLET | QD | |||||
| 126000603 | 12600060 | 2 | SS | DIOVAN D | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | (VALSARTAN 160, HYDROCHLOROTHIAZIDE 12.5) (3 YEARS AGO APPROXIMATELY) | U | 1538351 | 0 | ||||||||
| 126000603 | 12600060 | 3 | C | MELOXICAM. | MELOXICAM | 1 | Unknown | 150 MG, UNK | U | 0 | 150 | MG | |||||||
| 126000603 | 12600060 | 4 | C | MELOXICAM. | MELOXICAM | 1 | U | 0 | |||||||||||
| 126000603 | 12600060 | 5 | C | MELOXICAM. | MELOXICAM | 1 | U | 0 | |||||||||||
| 126000603 | 12600060 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 1 DF,QMO (1 DOSE PER MONTH) | U | 0 | 1 | DF | /month | ||||||
| 126000603 | 12600060 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | U | 0 | ||||||||||
| 126000603 | 12600060 | 8 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126000603 | 12600060 | 9 | C | SALBUTAMOL SULFATE | ALBUTEROL SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126000603 | 12600060 | 1 | Hypertension |
| 126000603 | 12600060 | 2 | Hypertension |
| 126000603 | 12600060 | 3 | Arthralgia |
| 126000603 | 12600060 | 4 | Osteoarthritis |
| 126000603 | 12600060 | 5 | Inflammation |
| 126000603 | 12600060 | 6 | Product used for unknown indication |
| 126000603 | 12600060 | 7 | Product used for unknown indication |
| 126000603 | 12600060 | 8 | Product used for unknown indication |
| 126000603 | 12600060 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126000603 | 12600060 | OT |
| 126000603 | 12600060 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126000603 | 12600060 | Abdominal pain | |
| 126000603 | 12600060 | Bronchial disorder | |
| 126000603 | 12600060 | Chest discomfort | |
| 126000603 | 12600060 | Chronic obstructive pulmonary disease | |
| 126000603 | 12600060 | Cough | |
| 126000603 | 12600060 | Dyspnoea | |
| 126000603 | 12600060 | General physical health deterioration | |
| 126000603 | 12600060 | Glaucoma | |
| 126000603 | 12600060 | Hepatic steatosis | |
| 126000603 | 12600060 | Hepatitis | |
| 126000603 | 12600060 | Hepatomegaly | |
| 126000603 | 12600060 | Hyperhidrosis | |
| 126000603 | 12600060 | Influenza | |
| 126000603 | 12600060 | Lung disorder | |
| 126000603 | 12600060 | Malaise | |
| 126000603 | 12600060 | Memory impairment | |
| 126000603 | 12600060 | Movement disorder | |
| 126000603 | 12600060 | Muscle spasms | |
| 126000603 | 12600060 | Nephrolithiasis | |
| 126000603 | 12600060 | Pain | |
| 126000603 | 12600060 | Pneumonia | |
| 126000603 | 12600060 | Pneumonitis | |
| 126000603 | 12600060 | Pyrexia | |
| 126000603 | 12600060 | Reading disorder | |
| 126000603 | 12600060 | Renal aneurysm | |
| 126000603 | 12600060 | Respiration abnormal | |
| 126000603 | 12600060 | Sciatica | |
| 126000603 | 12600060 | Spinal compression fracture | |
| 126000603 | 12600060 | Swelling | |
| 126000603 | 12600060 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |